Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A 52 wk Randomized, Doubleblind, Single Dummy, Parallel Group Multicenter Phase 3 Study Comparing the Long Term Safety of Symbicort pMDI 4x160/4.5mcg Bid to SymbicortpMDI 2x160/4.5mcg Bid & Budesonide HFA pMDI 4x160mcg Bid in Adult and Adolescent Subjects With Asthma
Brief Summary: The purpose of this study is to compare the long term safety of Symbicort with budesonide alone, in adolescents and adults with asthma.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: budesonide/formoterol | Arm Label: 2; Type: SHAM_COMPARATOR; Interventions: Drug: Symbicort pMDI + budesonide HFA pMDI | Intervention Type: DRUG; Name: budesonide/formoterol; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Symbicort pMDI + budesonide HFA pMDI; Assigned to Arm(s): 2
B: Arm Label: FS MDPI 100 / 12.5 mcg; Type: EXPERIMENTAL; Interventions: Drug: FS MDPI, Drug: albuterol/salbutamol, Drug: Beclomethasone dipropionate | Arm Label: FS MDPI 50 / 12.5 mcg; Type: EXPERIMENTAL; Interventions: Drug: FS MDPI, Drug: albuterol/salbutamol, Drug: Beclomethasone dipropionate | Arm Label: Fp MDPI 100 mcg; Type: EXPERIMENTAL; Interventions: Drug: Fp MDPI, Drug: albuterol/salbutamol, Drug: Beclomethasone dipropionate | Arm Label: Fp MDPI 50 mcg; Type: EXPERIMENTAL; Interventions: Drug: Fp MDPI, Drug: albuterol/salbutamol, Drug: Beclomethasone dipropionate | Arm Label: Placebo MDPI; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo MDPI, Drug: albuterol/salbutamol, Drug: Beclomethasone dipropionate | Intervention Type: DRUG; Name: FS MDPI; Assigned to Arm(s): FS MDPI 100 / 12.5 mcg, FS MDPI 50 / 12.5 mcg | Intervention Type: DRUG; Name: Fp MDPI; Assigned to Arm(s): Fp MDPI 100 mcg, Fp MDPI 50 mcg | Intervention Type: DRUG; Name: Placebo MDPI; Assigned to Arm(s): Placebo MDPI | Intervention Type: DRUG; Name: albuterol/salbutamol; Assigned to Arm(s): FS MDPI 100 / 12.5 mcg, FS MDPI 50 / 12.5 mcg, Fp MDPI 100 mcg, Fp MDPI 50 mcg, Placebo MDPI | Intervention Type: DRUG; Name: Beclomethasone dipropionate; Assigned to Arm(s): FS MDPI 100 / 12.5 mcg, FS MDPI 50 / 12.5 mcg, Fp MDPI 100 mcg, Fp MDPI 50 mcg, Placebo MDPI
C: Arm Label: QMF149 150/160 µg; Type: EXPERIMENTAL; Interventions: Drug: Indacaterol acetate/Mometasone furoate | Arm Label: QMF149 150/320 µg; Type: EXPERIMENTAL; Interventions: Drug: Indacaterol acetate/Mometasone furoate | Arm Label: MF 400 µg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mometasone furoate | Arm Label: Salmeterol /fluticasone 50/500 μg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Salmeterol xinafoate/fluticasone propionate | Arm Label: MF 800 μg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mometasone furoate | Intervention Type: DRUG; Name: Indacaterol acetate/Mometasone furoate; Assigned to Arm(s): QMF149 150/160 µg, QMF149 150/320 µg | Intervention Type: DRUG; Name: Mometasone furoate; Assigned to Arm(s): MF 400 µg, MF 800 μg | Intervention Type: DRUG; Name: Salmeterol xinafoate/fluticasone propionate; Assigned to Arm(s): Salmeterol /fluticasone 50/500 μg
D: Arm Label: CHF 5993 200/6/12.5 µg; Type: EXPERIMENTAL; Interventions: Drug: CHF 5993 200/6/12.5 µg | Arm Label: CHF 1535 200/6 µg; Type: ACTIVE_COMPARATOR; Interventions: Drug: CHF 1535 200/6 µg | Arm Label: CHF 1535 200/6 µg + Tiotropium Respimat 2.5 µg; Type: ACTIVE_COMPARATOR; Interventions: Drug: CHF 1535 200/6 µg + Tiotropium Respimat 2.5 µg | Intervention Type: DRUG; Name: CHF 5993 200/6/12.5 µg; Assigned to Arm(s): CHF 5993 200/6/12.5 µg | Intervention Type: DRUG; Name: CHF 1535 200/6 µg; Assigned to Arm(s): CHF 1535 200/6 µg | Intervention Type: DRUG; Name: CHF 1535 200/6 µg + Tiotropium Respimat 2.5 µg; Assigned to Arm(s): CHF 1535 200/6 µg + Tiotropium Respimat 2.5 µg

Answer: A